What's breaking now, across thousands of outlets.
Plus, news about Novartis. 🤝 Pfizer turns over ADC: The New York pharma is giving Medicus Pharma co-development rights to a CD228-targeted antibody-drug conjugate known as PF-08046031, a Seagen-derived asset that it ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Ms. Foundation For Women 2016 Gloria Awards Gala & After Party. NEW YORK, NY – APRIL 27: Journalist, social and political activist Gloria Steinem speaks on stage at Ms.
Researchers found 67 percent of Americans underreported having a dementia diagnosis, over double the rate for other conditions.
The Food and Drugs Authority (FDA) has ordered the recall of Arcan Bitters from the market after laboratory tests found that the product had been adulterated with Sildenafil Citrate.
(MedPage Today) -- Thomas Steffens, DO, the Colorado surgeon accused of shooting at federal agents who were trying to arrest him in Florida, has been indicted on multiple charges, including attempted…
Dr. Lal should hold discussions with various State-level agencies and officials, study the health sector issues in depth, and submit an interim report with his observations and recommendations to the…
Plus, news about Novonesis, Aspen, Fortrea and Northway. Alteogen and Novartis make a deal: The Swiss pharma is licensing Alteogen’s hyaluronidase enzyme, called ALT-B4, which is manufactured using a…
